SecurityNRK / Nuveen Insured New York AMT-Free Municipal Fund (670656107)
Institutional Owners86
Institutional Shares11,757,967
Institutional Value$ 143,878,000 USD

Institutional Stock Ownership and Shareholders

Nuveen Insured New York AMT-Free Municipal Fund (NYSE:NRK) has 86 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 11,757,967 shares. Largest shareholders include Karpus Management, Inc., Claybrook Capital, Llc, Morgan Stanley, Mackay Shields Llc, Edge Wealth Management LLC, Guggenheim Capital Llc, 1832 Asset Management L.P., Tortoise Investment Management, LLC, HighTower Advisors, LLC, and Royal Bank Of Canada.
Nuveen Insured New York AMT-Free Municipal Fund (NYSE:NRK) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR Invesco Ltd. 141,180 139,749 -1.01 1,830 1,699 -7.16
2018-01-16 13F-HR NEXT Financial Group, Inc 8,300 0 -100.00 109 0 -100.00
2018-04-26 13F-HR BEACON INVESTMENT ADVISORY SERVICES, INC. 11,563 11,563 0.00 150 141 -6.00
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 14,442 16,075 11.31 187 195 4.28
2018-05-21 13F-HR Summit Trail Advisors, Llc 30,913 55,592 79.83 393 56 -85.75
2018-05-09 13F-HR IFP Advisors, Inc 6 6 0.00 0 0
2018-04-27 13F-HR Barrett Asset Management, LLC 1,240 1,240 0.00 16 15 -6.25
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 359,544 350,814 -2.43 4,659 4,266 -8.44
2018-01-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 1,055 0 -100.00 14 0 -100.00
2018-05-16 13F-HR Israel Discount Bank of New York 27,850 23,250 -16.52 361 283 -21.61
2018-05-15 13F-HR Thomas J. Herzfeld Advisors, Inc. 10,000 10,000 0.00 130 122 -6.15
2018-05-10 13F-HR Stockman Asset Management 568 533 -6.16
2018-05-08 13F-HR DOLIVER CAPITAL ADVISORS, INC. 24,465 20,514 -16.15 317 249 -21.45
2018-05-10 13F-HR Bruderman Asset Management, LLC 4,000 49
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 24,092 27,509 14.18 312 335 7.37
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 59,238 65,763 11.01 768 799 4.04
2018-05-11 13F-HR TWIN FOCUS CAPITAL PARTNERS, LLC 10,233 10,233 0.00 133 124 -6.77
2018-05-15 13F-HR Ionic Capital Management LLC 20,000 243
2018-05-11 13F-HR MML INVESTORS SERVICES, LLC 33,397 23,879 -28.50 433 290 -33.03
2018-04-20 13F-HR FIRST MANHATTAN CO 3,845 1,034 -73.11 49 12 -75.51
2018-04-17 13F-HR INGALLS & SNYDER LLC 20,058 20,058 0.00 260 244 -6.15
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 0 11,650 0 142
2018-04-18 13F-HR Creative Planning 11,852 11,852 0.00 154 144 -6.49
2018-05-11 13F-HR LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 166,521 216,366 29.93 2,158 2,631 21.92
2018-05-14 13F-HR Karpus Management, Inc. 2,360,122 3,047,941 29.14 30,587 37,063 21.17
2018-05-02 13F-HR DIVIDEND ASSET CAPITAL, LLC 12,542 12,542 0.00 162 153 -5.56
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 115,720 139,246 20.33 1,500 1,693 12.87
2018-02-02 SC 13G BARCLAYS PLC 120
2018-05-08 13F-HR Neuberger Berman Group LLC 15,207 24,807 63.13 197 302 53.30
2018-05-15 13F-HR 1832 Asset Management L.P. 400,000 400,000 0.00 5,163 4,887 -5.35
2018-05-04 13F-HR WETHERBY ASSET MANAGEMENT INC 13,288 16,600 24.92 172 202 17.44
2018-05-09 13F-HR Cetera Advisor Networks LLC 13,745 0 -100.00 178 0 -100.00
2018-05-15 13F-HR UBS Group AG 361,251 338,832 -6.21 4,682 4,120 -12.00
2018-05-14 13F-HR LAZARD ASSET MANAGEMENT LLC 152 143 -5.92
2018-05-15 13F-HR CNH PARTNERS LLC 23,129 26,229 13.40 300 319 6.33
2018-05-11 13F-HR Claybrook Capital, Llc 1,015,965 1,016,511 0.05 13,167 12,361 -6.12
2018-05-09 13F-HR Cambridge Investment Research Advisors, Inc. 52,666 57,044 8.31 683 694 1.61
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 2,741 2,741 0.00 36 33 -8.33
2018-04-26 13F-HR TOMPKINS FINANCIAL CORP 1,318 1,318 0.00 17 16 -5.88
2018-05-11 13F-HR PINNACLE ASSOCIATES LTD 41,505 39,505 -4.82 538 480 -10.78
2018-05-15 13F-HR TWO SIGMA SECURITIES, LLC 12,447 12,891 3.57 161 157 -2.48
2018-04-27 13F-HR Mathes Company, Inc. 10,310 10,310 0.00 134 125 -6.72
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 519,016 510,895 -1.56 6,726 6,212 -7.64
2018-04-23 13F-HR Advisory Services Network, LLC 1,200 1,200 0.00 16 15 -6.25
2018-04-17 13F-HR Ronna Sue Cohen 32,086 32,351 0.83 416 393 -5.53
2018-05-11 13F-HR First Allied Advisory Services, Inc. 21,283 21,283 0.00 275 259 -5.82
2018-02-09 13F-HR Virtu Financial LLC 11,799 153
2018-04-05 13F-HR Edge Wealth Management LLC 345,807 515,389 49.04 4,475 6,267 40.04
2018-05-09 13F-HR STALEY CAPITAL ADVISERS INC 20,000 30,000 50.00 259 365 40.93
2018-05-11 13F-HR CITIGROUP INC 153,747 158,299 2.96 1,993 1,925 -3.41
2018-01-24 13F-HR SG Americas Securities, LLC 10,441 0 -100.00 138 0 -100.00
2018-04-16 13F-HR NWAM LLC 52,567 40,488 -22.98 681 492 -27.75
2018-04-19 13F-HR Janney Montgomery Scott LLC 27,470 32,714 19.09 356 398 11.80
2018-02-14 13F-HR MORGAN STANLEY 923,437 952,720 3.17 12,190 12,348 1.30
2018-05-15 13F-HR ROBINSON CAPITAL MANAGEMENT, LLC 68,155 827
2018-05-15 13F-HR DEUTSCHE BANK AG\ 1,292 1,292 0.00 16 15 -6.25
2018-02-02 13F-HR Armbruster Capital Management, Inc. 647 0 -100.00 9 0 -100.00
2018-04-16 13F-HR IFC Holdings Incorporated/FL 15,559 0 -100.00 199 0 -100.00
2018-05-15 13F-HR FIFTH THIRD BANCORP 925 925 0.00 12 11 -8.33
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 50,605 56,667 11.98 663 748 12.82
2018-05-15 13F-HR Bank of New York Mellon Corp 15,721 0 -100.00 204 0 -100.00
2018-05-15 13F-HR Squarepoint Ops LLC 27,187 0 -100.00 352 0 -100.00
2018-05-15 13F-HR LPL Financial LLC 49,600 62,038 25.08 643 754 17.26
2018-01-16 13F-HR Strategic Advisors LLC 43,763 0 -100.00 578 0 -100.00
2018-05-14 13F-HR King Wealth Management Group, LLC 0 13,252 0 161
2018-05-15 13F-HR CREDIT SUISSE AG/ 19,973 19,973 0.00 258 243 -5.81
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 40,189 17,078 -57.51 521 208 -60.08
2018-05-10 13F-HR Winfield Associates, Inc. 1,400 0 -100.00 19 0 -100.00
2018-02-14 13F-HR WOLVERINE ASSET MANAGEMENT LLC 1,621 0 -100.00 21 0 -100.00
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 6,278 6,293 0.24 82 76 -7.32
2018-05-15 13F-HR Advisor Group, Inc. 83,758 73,787 -11.90 1,085 897 -17.33
2018-05-14 13F-HR INFRASTRUCTURE CAPITAL ADVISORS, LLC 50,600 50,600 0.00 656 615 -6.25
2018-04-27 13F-HR Deschutes Portfolio Strategy, LLC 12,100 12,100 0.00 157 147 -6.37
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 221,969 195,910 -11.74 2,877 2,383 -17.17
2018-04-17 13F-HR Calton & Associates, Inc. 10,032 10,048 0.16 127 122 -3.94
2018-05-15 13F-HR Circle Wealth Management, LLC 19,477 19,699 1.14 252 240 -4.76
2018-05-15 13F-HR HighTower Advisors, LLC 334,862 355,837 6.26 4,334 4,323 -0.25
2018-05-01 13F-HR WHITTIER TRUST CO 1,802 1,802 0.00 23 22 -4.35
2018-05-15 13F-HR Mariner Wealth Advisors, LLC 39,657 39,657 0.00 514 482 -6.23
2018-05-03 13F-HR Essex Financial Services, Inc. 11,629 11,629 0.00 151 141 -6.62
2018-05-11 13F-HR Fiera Capital Corp 180,029 302,450 68.00 2,333 3,678 57.65
2018-05-15 13F-HR Wall Street Access Asset Management, LLC 17,104 47,666 178.68 221 579 161.99
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 43,475 55,016 26.55 563 669 18.83
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 2 0 -100.00 0 0
2018-05-15 13F-HR Horizon Kinetics LLC 15,129 72,999 382.51 196 888 353.06
2018-04-17 13F-HR NAPLES GLOBAL ADVISORS, LLC 232,970 206,255 -11.47 3,019 2,508 -16.93
2018-05-03 13F-HR MACKAY SHIELDS LLC 648,590 648,590 0.00 8,406 7,887 -6.17
2018-05-10 13F-HR Tortoise Investment Management, LLC 226,710 384,669 69.67 2,938 4,678 59.22
2018-05-11 13F-HR CITY OF LONDON INVESTMENT MANAGEMENT CO LTD 136,200 1,658
2018-04-12 13F-HR Bogart Wealth, Llc 4,223 4,223 0.00 55 51 -7.27
2018-05-11 13F-HR STIFEL FINANCIAL CORP 25,547 15,590 -38.98 332 189 -43.07
2018-05-03 13F-HR HUDSON CANYON INVESTMENT COUNSELORS LLC 2,770 34
2018-05-15 13F-HR Weiss Asset Management LP 0 19,274 0 234
2018-05-14 13F-HR RMB Capital Management, LLC 0 43,514 0 529
2018-05-11 13F-HR M&R CAPITAL MANAGEMENT INC 3,658 3,658 0.00 47 44 -6.38
2018-04-20 13F-HR Seacrest Wealth Management, Llc 19,538 19,538 0.00 253 238 -5.93
2018-05-11 13F-HR SEI INVESTMENTS CO 569 2,243 294.20 7 27 285.71
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 300,895 281,648 -6.40 3,900 3,425 -12.18
2018-02-14 13F-HR National Planning Corp 54,000 0 -100.00 713 0 -100.00

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 670656107